Wenzhou Kangning Hospital Co. Ltd (4WK) - Total Liabilities

Latest as of December 2025: €1.71 Billion EUR ≈ $2.00 Billion USD

Based on the latest financial reports, Wenzhou Kangning Hospital Co. Ltd (4WK) has total liabilities worth €1.71 Billion EUR (≈ $2.00 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Wenzhou Kangning Hospital Co. Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Wenzhou Kangning Hospital Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Wenzhou Kangning Hospital Co. Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Wenzhou Kangning Hospital Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Wenzhou Kangning Hospital Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Lleidanetworks Serveis Telematics SA
MC:LLN
Spain €11.70 Million
Hanchang Ind.Co.Ltd
KQ:079170
Korea ₩13.88 Billion
Naos Ex-50 Opportunities Company Ltd
AU:NAC
Australia AU$18.30 Million
Redflow Ltd
AU:RFX
Australia AU$9.47 Million
Asuransi Ramayana Tbk
JK:ASRM
Indonesia Rp1.24 Trillion

Liability Composition Analysis (2016–2025)

This chart breaks down Wenzhou Kangning Hospital Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Wenzhou Kangning Hospital Co. Ltd (4WK) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.31 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.44 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wenzhou Kangning Hospital Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wenzhou Kangning Hospital Co. Ltd (2016–2025)

The table below shows the annual total liabilities of Wenzhou Kangning Hospital Co. Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €1.71 Billion
≈ $2.00 Billion
+3.15%
2024-12-31 €1.66 Billion
≈ $1.94 Billion
+1.35%
2023-12-31 €1.64 Billion
≈ $1.92 Billion
+24.97%
2022-12-31 €1.31 Billion
≈ $1.53 Billion
+18.52%
2021-12-31 €1.11 Billion
≈ $1.29 Billion
+18.44%
2020-12-31 €934.52 Million
≈ $1.09 Billion
+9.19%
2019-12-31 €855.84 Million
≈ $1.00 Billion
+34.68%
2018-12-31 €635.45 Million
≈ $742.91 Million
+9.58%
2017-12-31 €579.90 Million
≈ $677.97 Million
+3.18%
2016-12-31 €562.01 Million
≈ $657.05 Million
--

About Wenzhou Kangning Hospital Co. Ltd

F:4WK Germany Medical Care Facilities
Market Cap
$18.15 Million
€15.52 Million EUR
Market Cap Rank
#25447 Global
#2198 in Germany
Share Price
€0.88
Change (1 day)
+2.92%
52-Week Range
€0.84 - €1.06
All Time High
€1.06
About

Wenzhou Kangning Hospital Co., Ltd., together with its subsidiaries, operates a network of healthcare facilities in the People's Republic of China. The company provides psychiatric specialty care and elderly rehabilitation services. It is also involved in property leasing and management; provision of hospital management, medical services, technology, and nursing care services; drug retail and pha… Read more